NCT06212193 - Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2030

Conditions

Tricuspid RegurgitationTricuspid Regurgitation Functional

Interventions

DEVICE

Trillium™

Trillium™ Stent Graft for Cross-Caval Tricuspid Valve Replacement

Trial Locations (12)

10065

RECRUITING

Weill Cornell Medicine, New York

11794

RECRUITING

Stony Brook Heart Institute, Stony Brook

13353

RECRUITING

German Heart Center at Charité (DHZC), Berlin

19096

RECRUITING

Lankenau Heart Institute, Philadelphia

37203

RECRUITING

TriStar Centennial Medical Center, Nashville

45219

RECRUITING

The Christ Hospital, Cincinnati

48236

RECRUITING

Ascension St. John, Detroit

55131

RECRUITING

University Medicine Mainz, Mainz

55902

RECRUITING

Mayo Clinic Hospital (Rochester), Rochester

91360

RECRUITING

Cardiovascular Institute of Los Robles Health System, Thousand Oaks

98195

RECRUITING

University of Washington Medical Center, Seattle

04103

RECRUITING

Helios Health Institute GmbH, Leipzig, Leipzig

All Listed Sponsors

collaborator

Innoventric Inc.

UNKNOWN

lead

Innoventric LTD

INDUSTRY